Abstract
The effects of depletion of the serotonin precursor,l-tryptophan, on the threshold and tolerance to cold pressor pain, and the analgesic effect of morphine (10 mg intramuscularly), were tested in a double blind trial on human volunteers. Effects on mood were also assessed using the Profile of Mood States and the Addiction Research Center Inventory (ARCI) Scales. To deplete tryptophan, subjects were fed a tryptophan-deficient amino acid mixture 4.5 h before morphine was administered. Controls received the mixture with tryptophan, which is equivalent to a nutritionally balanced protein. The tryptophan-deficient meal reduced plasma tryptophan more than 70% but had no effect on threshold or tolerance to cold pressor pain. After morphine, tolerance to cold pressor pain increased in controls. Tryptophan depletion abolished this analgesic effect. Pain threshold was not altered by morphine. In subjects with normal tryptophan, the analgesic effect of morphine was predicted by the level of plasma morphine-6-glucuronide, but not by the level of morphine. Morphine increased scores on the LSD scale of the ARCI, but had no effect on other measures of mood. Tryptophan depletion also failed to alter mood in these subjects, who had unusually low depression scores before tryptophan depletion.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbott FV, Melzack R (1982) Brainstem lesions dissociate neural mechanisms of morphine analgesia in different kinds of pain. Brain Res 251:149–155
Abbott FV, Palmour RM (1988) Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. Life Sci 43:1685–1695
Abbott FV, Young SN (1988) Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin test. Pharmacol Biochem Behav 31:855–860
Abbott FV, Melzack R, Samuel C (1982) Morphine analgesia in the tail-flick and formalin pain tests is mediated by different neural systems. Exp Neurol 75:644–651
Beecher HK (1959) Measurement of subjective responses: quantitative effects of drugs. Oxford University Press, New York
Chapman LF, Dingman HF, Ginzberg SP (1965) Failure of analgesic agents to alter the absolute sensory threshold for simple detection of pain. Brain 88:1101
Chen ACN, Treede R (1985) The McGill Pain Questionnaire in the assessment of phasic and tonic experimental pain: behavioral evaluation of the “pain inhibiting pain” effect. Pain 22:67–79
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Arch Gen Psychiatry 47:411–418
Denckla WD, Dewey HK (1967) The determination of tryptophan in plasma, liver and urine. J Lab Clin Med 69:160–169
Fasmer OB, Post C, Hole K (1987) Changes in nociception after acute and chronic administration of zimelidine: different effects in the formalin test and the Substance P behavioural assay. Neuropharmacology 26:309–312
Fernstrom JD (1983) Role of monoamine precursor availability in control of monoamine synthesis in brain. Physiol Rev 63:484–546
Franklin KBJ, Abbott FV (1989) Techniques for assessing the effects of drugs on nociceptive responses. In: Boulton AA, Baker CB, Greenshaw AJ (eds) Neuromethods: vol 13, Psychopharmacology I. Humana Press, New Jersey, pp 145–216
Franklin KBJ, Abbott FV, English MJM, Jeans ME, Tasker RAR, Young SN (1990) Tryptophan-morphine interactions and post-operative pain. Pharmacol Biochem Behav 35:157–163
Gorlitz B-D, Frey H-H (1972) Central monoamines and antinociceptive drug action. Eur J Pharmacol 20:171–180
Haertzen CA (1974) An overview of addiction research center inventory scales (ARCI): An appendix and manual of scales. National Institute on Drug Abuse, Rockville, MD, pp 1–127
Haertzen CA, Hickey JE (1987) Addiction research center inventory (ARCI): measurement of euphoria and other drug effects. In: Bozarth MA (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, Berlin Heidelberg New York, pp 489–524
Hand CW, Blunnie WP, Claffey JP, McShane AJ, McQuay HJ, Moore RA (1987) Potential anaglesic contribution from morphine-6-glucuronide in GSF. Lancet ii:1207–1208
Hill HE, Haertzen CA, Wolbach AB, Miner EJ (1963) The Addiction Research Center Inventory: standardization of scales which evaluate subjective effects of morphine, amphetamine, pentobarbital, alcohol LSD-25, pyrahexyl and chlorpromazine. Psychopharmacologia 4:167–183
Holland RL, Harkin NE, Coleshaw SRK, Jones DA, Peck AW, Telekes A (1987) Dipipanone and nifedipine in cold induced pain; analgesia not due to skin warming. Br J Clin Pharmacol 24:823–826
Hosobuchi Y, Lamb S, Bascom D (1980) Tryptophan loading may reverse tolerance to opiate analgesics in humans: a preliminary report. Pain 9:161–169
Jaffe JH, Martin WR (1990) Opioid agonists and antagonists. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 485–519
Jarvik LF, Simpson JH, Guthrie D, Liston EH (1981) Morphine, experimental pain and psychological reactions. Psychopharmacology 75:124
Jasinski DR, Preston KL (1987) A comparative assay of nefopam, morphine andd-amphetamine. Psychopharmacology 91:273–278
Keats AS, Telford J (1957) Subjective effects of nalorphine in hospitalized patients. J Pharmacol Exp Ther 119:370–377
Keats AS, Telford J (1960) Studies of analgesic drugs V. The comparative subjective effects of oxymorphone and morphine. Clin Pharmacol Ther 1:703–707
LaMotte RH (1982) Psychophysical studies of the effects of opioid analgesics on experimentally induced pain. In: Kitahata LM, Collins JG (eds) Narcotic analgesics in anesthesiology. Williams & Wilkins, Baltimore/London, pp 209–234
Martin WR, Fraser HF (1961) A comparative study of physiological and subjective effects of heroin and morphine administered intravenously in postaddicts. J Pharmacol Exp Ther 133:388–399
McNair DM, Lorr M, Droppleman LF (1988) EDITS Manual for the profile of mood states, Educational and Industrial Testing Service, San Diego, California
Osborne R, Joel S, Trew D, Slevin M (1988) Analgesic activity of morphine-6-glucuronide. Lancet i:828
Posner J, Telekes A, Crowley D, Phillipson R, Peck AW (1985) Effects of an opiate on cold-induced pain and the CNS in healthy volunteers. Pain 23:73–82
Price DD, Von der Gruen A, Miller J, Rafii A, Price C (1985) A psychophysical analysis of morphine analgesia. Pain 22:261–269
Price DD, Harkins SW, Rafii A, Price C (1986) A simultaneous comparison of fentanyl's analgesic effects on experimental and clinical pain. Pain 24:197–203
Roe A (1961) The psychology of the scientist. Science 134:456–459
Ryan SM, Watkins LR, Mayer DJ, Maier SF (1985) Spinal pain suppression mechanisms may differ for phasic and tonic pain. Brain Res 334:173–175
Sawe J, Kager L, Svensson J-O, Rane A (1985) Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. Br J Clin Pharmacol 19:495–501
Shimomura K, Kamata O, Ueki S, Ida S, Oguri K, Yoshimura H, Tsukamoto H (1971) Analgesic effect of morphine glucuronides. Tohoku J Exp Med 105:45–52
Smith GM, Beecher HK (1959) Measurement of “mental clouding” and other subjective effects of morphine. J Pharmacol Exp Ther 126:50–62
Smith GM, Beecher HK (1962) Subjective effects of heroin and morphine in normal subjects. J Pharmacol Exp Ther 136:47–52
Smith SE, Pihl RO, Young SN, Ervin FR (1986) Elevation and reduction of plasma tryptophan and their effects on aggression and perceptual sensitivity in normal males. Aggress Behav 12:393–407
Smith SE, Pihl RO, Young SN, Ervin FR (1987) A test of possible cognitive and environmental influences on the mood lowering effect of tryptophan depletion in normal males. Psychopharmacology 91:451–457
Stanski DR, Greenblatt DJ, Lowenstein E (1978) Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 24:52–59
Svensson J-O, Rane A, Säwe J, Sjöqvist F (1982) Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high performance liquid chromatography. J Chromatogr 230:427–432
Tenen SS (1968) Antagonism of the analgesic effect of morphine and other drugs byp-chlorophenylalanine, a serotonin depletor. Psychopharmacologia 12:278–285
Tulunay FC, Yano I, Takemori AE (1976) The effect of biogenic amine modifiers on morphine analgesia and its antagonism by naloxone. Eur J Pharmacol 35:285–292
Vogt M (1974) The effect of lowering the 5-hydroxytryptamine content of the rat spinal cord on analgesia produced by morphine. J Physiol (Lond) 236:483–498
Wolff BB, Kantor TJ, Jarvik ME, Laska E (1966) Response of experimental pain to analgesic drugs. I. Morphine, aspirin and placebo. Clin Pharmacol Ther 7:224–238
Wurtman RJ, Hefti F, Melamed (1981) Precursor control of neurotransmitter synthesis. Pharmacol Rev 32:315–335
Yaksh TJ (1979) Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res 160:180–185
Young SN, Gauthier S (1981) Effect of tryptophan administration on tryptophan, 5-Hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 44:323–328
Young SN, Smith SE, Pihl RO, Ervin FR (1985) Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology 87:173–177
Young SN, Tourjman SV, Teff K, Pihl RO, Ervin FR, Anderson GH (1988) The effect of lowering plasma tryptophan on food selection in normal males. Pharmacol Biochem Behav 31:149–152
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abbott, F.V., Etienne, P., Franklin, K.B.J. et al. Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108, 60–66 (1992). https://doi.org/10.1007/BF02245286
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245286